
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Eudralex
- Vol 7: Medicinal Products Veterinary

Reference documents
- Reference documents
- Eudralex
- Vol 7: Medicinal Products Veterinary
EudraLex - Volume 7 Scientific guidelines for medicinal products for veterinary use
Volume 7 of the publications "The rules governing medicinal products in the European Union" contains scientific guidelines prepared by the Committee for Medicinal Products for Human Use (CHMP) in consultation with the competent authorities of the EU Member States, to help applicants prepare marketing-authorisation applications for medicinal products for human use.
Guidelines are intended to provide a basis for practical harmonisation of the manner in which the EU Member States and the EMEA interpret and apply the detailed requirements for the demonstration of quality, safety and efficacy contained in the Community directives. They also help to ensure that applications for marketing authorisation are prepared in a manner that will be recognised as valid by the EMEA.
Volume 7A - General, efficacy, environmental risk assessment
-
Introduction
(18 KB)
- Guidelines for production and control of immunological veterinary medicinal products
-
Guideline for an assessor preparing assessment reports for veterinary medicinal products
(175 KB)
-
Variation assessment report (var) for veterinary medicinal products in the centralised and mutual recognition procedures
(61 KB)
-
Minimising the risk of transmitting agents causing spongiform encephalopathy via veterinary medicinal products
(94 KB)
-
Oecd principles of good laboratory practice
(53 KB)
- Guidelines for efficacy testing of veterinary medicinal products
-
Good clinical practice for the conduct of clinical trials on veterinary medicinal products in the European union
(73 KB)
-
Evaluation of the safety of veterinary medicinal products for the target animals
(37 KB)
-
Conduct of pharmacokinetic studies in animals
(28 KB)
-
Conduct of bioequivalence studies in animals
(45 KB)
-
Fixed combination products
(21 KB)
-
Performance enhancers
(26 KB)
-
Veterinary medicinal products for zootechnical purposes
(21 KB)
-
Antimicrobials for general veterinary use in target species (excluding intramammary preparations)
(26 KB)
-
Anthelmintics: general requirements
(92 KB)
-
Anthelmintics for swine: specific requirements
(33 KB)
-
Anthelmintics for bovines and ovines: specific requirements
(43 KB)
-
Equine anthelmintics: specific requirementst
(34 KB)
-
Anthelmintics for cats and dogs: specific requirements
(29 KB)
-
Veterinary medicinal products for fluid therapy in case of diarrhoea
(24 KB)
-
Anticoccidials used for the therapy of coccidiosis in chickens, turkeys and geese
(91 KB)
-
Veterinary medicinal products controlling varroa jacobsoni and acarapis woodi parasitosis in bees
(33 KB)
-
Demonstration of efficacy of ectoparasiticides
(35 KB)
-
Veterinary medicinal products administered via the teat duct to lactating cows for the treatment of clinical mastitis
(22 KB)
-
Veterinary medicinal products administered via the teat duct to lactating cows for the treatment of subclinical mastitis
(74 KB)
-
Veterinary medicinal products administered via the teat duct to cows at drying off for the treatment of subclinical mastitis and the prevention of new infections
(21 KB)
-
Local tolerance of intramammary preparations in cows
(17 KB)
-
Efficacy of veterinary medicinal products for use in farmed aquatic species
(68 KB)
- Guidelines For The Assessment Of The Environmental Risk Of The Use Of Veterinary Medicinal Products
-
Environmental risk assessment for veterinary medicinal products other than gmo-containing and immunological products
(278 KB)
-
Environmental risk assessment for immunological veterinary medicinal products
(38 KB)
-
Environmental risk assessment which must accompany applications for marketing authorisation of veterinary medicinal products which contain or consist of genetically modified organisms (gmos)
(289 KB)
-
List of abreviations
(20 KB)
-
List of legislation
(20 KB)
Volume 7B - Immunologicals, quality
-
Introduction
(18 KB)
- Guidelines for production and control of immunological veterinary medicinal products
-
General requirements for the production and control of live mammalian bacterial and viral vaccines for veterinary use
(81 KB)
-
General requirements for the production and control of inactivated mammalian bacterial and viral vaccines for veterinary use
(84 KB)
-
Specific requirements for the production and control of avian live and inactivated viral and bacterial vaccines
(67 KB)
-
Specific requirements for the production and control of bovine live and inactivated viral and bacterial vaccines
(27 KB)
-
Specific requirements for the production and control of pig live and inactivated viral and bacterial vaccines
(23 KB)
-
Specific requirements for the production and control of ovine and caprine live and inactivated viral and bacterial vaccines
(28 KB)
-
Specific requirements for the production and control of equine live and inactivated viral and bacterial vaccines
(21 KB)
-
Harmonisation of requirements for equine influenza vaccines specific requirements for substitution of a strain
(35 KB)
-
Specific requirements for the production and control of live and inactivated vaccines intended for fish
(29 KB)
-
Table of extraneous agents to be tested for in relation to the general and species specific guidelines on production and control of mammalian veterinary vaccines
(144 KB)
-
Specific requirements for the production and control of allergen products
(50 KB)
-
Specific requirements for the production and control of immunosera and colostrum substitutes
(35 KB)
-
Specific requirements for the production and control of live and inactivated viral and bacterial vaccines for cats and dogs
(36 KB)
-
Inclusion of antimicrobial preservatives in immunological veterinary medicinal products
(21 KB)
- Quality guidelines
-
Manufacture of the finished dosage form
(36 KB)
-
In use stability testing of veterinary medicinal products (excluding immunological veterinary medicinal products)
(23 KB)
-
Additional quality requirements for products intended for incorporation into animal feedingstuffs (medicated pre-mixes)
(23 KB)
-
Investigation of chiral active substances
(49 KB)
-
Inclusion of antioxidants and antimicrobial preservatives in medicinal products
(26 KB)
-
List of quality guidelines accepted from the guidelines for human use
(13 KB)
-
List of abreviations
(23 KB)
-
List of legislation
(20 KB)
-
Index
(15 KB)


